Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

Page 72

M&A

Drinks With The Deal: Chris Varelas

By David Marcus
|
Published: December 6th, 2019
The former Citi tech investment banker and author of 'How Money Became Dangerous' talks with The Deal’s David Marcus about working at Disneyland in the 1980s, being a tech banker after the dot-com crash and investing in influencers.
Activism

Inside Hudson Executive’s USA Tech Battle

By Ronald Orol
|
Published: December 6th, 2019
The activist fund’s mission statement says it won't launch public proxy fights, but Hudson Executive nevertheless is set for one at the digital payments technology company.
M&A

Discipline Crucial in 2020

By Alexandra Garfinkle
|
Published: December 2nd, 2019
M&A valuations remain frothy and Ebitda adjustments are growing, panelists cautioned at The 2019 Deal Economy Conference.
Activism

Vitamin Shoppe to Emphasize Organic Growth

By Alexandra Garfinkle
|
Published: December 2nd, 2019
Vitamin Shoppe GC David Kastin said that the company will pursue organic growth, while its soon-to-be parent pursues M&A.
Activism

Activists Find New Routes to M&A Opportunities

By Ronald Orol
|
Published: December 2nd, 2019
Insurgent managers are targeting larger companies and are taking on different roles, a panel of experts told The Deal Economy's 2019 conference.
Private Equity

PE Pros Talk Deal Pipeline

By Armie Margaret Lee
|
Published: December 2nd, 2019
Eurazeo's Vivianne Akriche told attendees at The Deal Economy conference on Wednesday that the pipeline is 'pretty full' for next year.
Activism

ESG Not Just a PC Term

By Greg Morcroft
|
Published: December 2nd, 2019
Corporations struggling to adapt to an investment community increasingly focused on improving environmental, social, and governance behavior may instead be missing an opportunity, according to a panel discussion at the Deal Economy Conference.
Activism

M&A, Politics, SEC Top of Mind for Activists

By Ronald Orol
|
Published: December 2nd, 2019
Schulte Roth partner Aneliya Crawford discusses activism at large-cap companies, BMY-Celgene and insurgent prospects in a second Trump or Warren administration at The Deal Economy conference.